Our Story

A personal & scientific commitment to a future without Alzheimer’s

SYNAPTYS neuroscience was not simply born from a scientific idea, but from a deeply personal commitment. Its President, Sébastien Lasnier, witnessed firsthand the devastating effects of Alzheimer’s disease, which shaped his entrepreneurial and scientific journey.

«Like many families, I saw with my own eyes the impact of this disease when my grandmother was affected. Surrounded by her loved ones, we managed to extend her life after the first signs appeared, but under extremely difficult conditions for her and our entire family. This experience deeply affected me and strengthened my determination to find solutions to improve the quality of life for Alzheimer’s patients and their families.»

Sébastien Lasnier

Building on this experience and his professional background in the pharmaceutical industry, Sébastien Lasnier decided to fully dedicate himself to the fight against Alzheimer’s by creating SYNAPTYS neuroscience, a company dedicated to finding a therapeutic response to this devastating disease. The goal i clear: to offer hope to the millions of people who struggle every day with Alzheimer’s disease by providing an innovative, patient-centered approach.

Since its creation, SYNAPTYS neuroscience has relied on a passionate team of researchers and cutting-edge technology to develop SYS-0108, a new approach that could transform the lives of patients affected by Alzheimer’s. This mission is driven by the belief that science, when combined with human experience, can truly transform lives..

Discover our innovation